Participate in an imaging revolution.

iThera Medical offers the next generation in molecular imaging. 
Introducing MSOT - Multispectral Optoacoustic Tomography.

With its unique ability to accurately visualize and quantify tissue molecules, nanoparticles, biomarkers and optical agents, in vivo and in real time, through several centimeters of tissue, MSOT stands at the forefront of the next era in biomedical imaging.

MSOT Small Animal Imaging

iThera Medical offers a range of small animal scanners with varying hardware and software configurations. All systems enable whole-body deep-tissue imaging in real time.

For more information: click here.

Opens video in new window

MSOT inVision Experiment Workflow

iThera Medical's MSOT imaging systems facilitate a wide variety of imaging applications as well as extensive data analysis, and are yet easy to use. To get a first-hand impression of the MSOT experiment procedure for small animal studies, follow this link: play video

MSOT Clinical Translation

Based on the real-time multispectral imaging technology proven in iThera Medical’s MSOT inSight / inVision small animal imaging systems, an MSOT imaging system for exploratory clinical use, the MSOT EIP (Experimental Imaging Platform), is now available.

For more information: click here.

xPLORE Probes

iThera Medical markets a proprietary line of probes optimized for the use with MSOT. The initial portfolio of three xPLORE© probes consists of two targeted reagents for the use in disease models related to cancer and inflammation as well as one blood pool agent with long circulation time.

For more information: click here.

Application Highlight: DCE-MSOT

MSOT has the capability to capture fast processes in vivo with high spatiotemporal resolution. Per-pixel analysis allows fitting of a pharmacokinetic model and calculation of parametric maps. Related applications include perfusion and probe targeting / clearance studies: see poster

  • Ye S et al.,
    Engineering Gold Nanotubes with Controlled Length and Near-Infrared Absorption for Theranostic Applications,
    Adv. Funct. Mater. (2015). DOI: 10.1002/adfm.201404358.
  • Amalina Bte Ebrahim Attia et al.,
    Phthalocyanine photosensitizers as contrast agents for in vivo photoacoustic tumor imaging,
    Biomedical Optics Express, Vol. 6, Issue 2, pp. 591-598 (2015). DOI: 10.1364/BOE.6.000591.
  • Gottschalk S et al.,
    Noninvasive real-time visualization of multiple cerebral hemodynamic parameters in whole mouse brains using five-dimensional optoacoustic tomography,
    J Cereb Blood Flow Metab. 2015 Jan 14. DOI: 10.1038/jcbfm.2014.249.
  • Balasundaram G et al.,
    Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer,
    Int J Nanomed. 2015:10 387–397. DOI: 10.2147/IJN.S73558
  • Press AT et al.,
    Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles,
    Nat Commun. 2014 Dec 3;5:5565. DOI: 10.1038/ncomms6565.
    Page layout: 0
    Page level: 2